371
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Negotiating Competing Discourses: The Decision to Take Menopausal Hormone Therapy Following Surgical Menopause

, , &
Pages 527-543 | Received 08 Mar 2010, Accepted 04 Aug 2010, Published online: 27 Oct 2010

REFERENCES

  • Banks , E. and Canfell , K. 2009 . Invited commentary: Hormone therapy risks and benefits—The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis . Am J Epidemiol , 170 : 24 – 8 .
  • Barrett-Connor , E. 2002 . Hormones and the health of women: Past, present, and future. Keynote address . Menopause , 9 : 23 – 31 .
  • Boorse , C. 1977 . Health as a theoretical concept . Philos Sci , 44 : 542 – 73 .
  • Buist , D. S. M. , Newton , K. M. , Miglioretti , D. L. , Beverly , K. , Connelly , M. T. Andrade , S. 2004 . Hormone therapy prescribing patterns in the United States . Obstet Gynaecol , 104 : 1042 – 50 .
  • Burrell , B. A. 2009 . The replacement of the replacement in menopause: Hormone therapy, controversies, truth, and risk . Nurs Inquiry , 16 : 212 – 22 .
  • Crawford , R. 2004 . Risk ritual and the management of control and anxiety in medical culture . Health: Interdisc J Soc Study Health, Illness & Med , 8 : 505 – 28 .
  • Dennerstein , L. 1996 . Well-being, symptoms and the menopausal transition . Maturitas , 23 : 147 – 57 .
  • Ettinger , B. , Grady , D. , Tosteson , A. , Pressman , A. and Macer , J. 2003 . Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy . The American College of Obstetricians and Gynecologists , 102 ( 6 ) : 1225 – 1232 .
  • FDA. 2004 . FDA updates hormone therapy information for post menopausal women Retrieved May 20, 2010, from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108243.htm
  • Foidart , J. M. , Desreux , J. , Pintiaux , A. and Gompel , A. 2007 . Hormone therapy and breast cancer risk . Climacteric , 10 : 54 – 61 .
  • Foucault , M. 1972/1980 . Power/knowledge: Selected interviews and other writings 1972–77 Edited by: Gordon , C. , Gordon , C. , Marshall , L. , Mepham , J. and Soper , K. Brighton, , U.K. : Harvester Press .
  • Foucault , M. 1977 . Discipline and punish: The birth of the prison. London : Penguin. .
  • Foucault , M. 1988 . “ Technologies of the self ” . In Technologies of the self: A seminar with Michel Foucault Edited by: Gutman , M. L. and Hutton , P. Amherst, MA : University of Massachusetts .
  • Foucault , M. 1998 . “ On the archaeology of the sciences: Response to the epistemological circle ” . In Aesthetics, method, and epistemology Edited by: Faubion , J. 297 – 333 . New York : The New Press .
  • Galvin , R. 2002 . Disturbing notions of chronic illness and individual responsibility: Towards a genealogy of morals . Health: Interdisc J Soc Study Health, Illness & Med , 6 : 107 – 37 .
  • Grady , D. , Herrington , D. , Bittner , V. , Blumenthal , R. , Davidson , M. and Hlatky , M. 2002 . Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow up (HERS11) . J Am Med Assoc , 288 : 49 – 57 .
  • Hammond , C. 2005 . The Women's Health Initiative Study: Perspectives and implications for clinical practice . Rev Endocr & Metabol Disord , 6 : 93 – 9 .
  • Hendrix , S. 2005 . Bilateral oopherectomy and premature menopause . Am J Med , 118 : 131S – 5S .
  • Hersh , A. L. , Stefanick , M. and Stafford , R. 2004 . National use of postmenopausal hormone therapy: Annual trends and response to recent evidence . J Am Med Assoc , 291 : 47 – 53 .
  • Hickey , M. , Davis , S. and Sturdee , D. 2005 . Treatment of menopausal symptoms; What shall we do now? . Lancet , 366 : 409 – 21 .
  • Hoffmann , M. , Lindh-Astrand , L. , Ahlner , J. , Hammar , M. and Kjellgren , K. 2005 . Hormone replacement therapy in the menopause. Structure and content of risk talk . Maturitas , 50 : 8 – 18 .
  • Hulley , S. , Furberg , C. , Barrett-Connor , E. , Cauley , J. , Grady , D. Haskell , W. 2002 . Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow up (HERS11) . J Am Med Assoc , 288 : 58 – 64 .
  • Hulley , S. , Grady , D. , Bush , T. , Furberg , C. , Herrington , D. , Riggs , B. and Vittinghoff , E. 1998 . Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . J Am Med Assoc , 280 : 605 – 613 .
  • Institute for Quality and Efficiency in Health Care Germany. 2006, 2007 . Decision aid: Hormone therapy for menopause Retrieved from informedhealthonline.org
  • Institute for Quality and Efficiency in Health Care Germany. 2007 . Menopause Retrieved December 7, 2007, from http://www.informedhealthonline.org/index.161.en.html
  • Krieger , N. , Lowy , I. , Aronowitz , R. , Bigby , J. , Dickersin , K. Garner , E. 2005 . Hormone replacement therapy, cancer, controversies, and women's health: Historical, epidemiological, biological, clinical, and advocacy perspectives . J Epidemiol & Commun Health , 59 : 740 – 748 .
  • Majumdar , S. , Almasi , A. and Stafford , R. 2004 . Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative . J Am Med Assoc , 292 : 1983 – 8 .
  • McCrea , F. B. 1983 . The politics of menopause: The discovery of a deficiency disease . Soc Problems , 31 : 111 – 23 .
  • National Heart, Lung, and Blood Institute. 2005 . Facts about menopausal hormone therapy, , 2nd Ed. original 2002. Retrieved December 4, 2007, from http://www.nhlbi.nih.gov/health/public/heart/other/pht_fact.htm
  • National Institutes of Health. 2005 . State-of-the-Science Conference Statement: Management of menopause-related symptoms . Ann Int Med , 142 : 1003 – 13 .
  • National Institutes of Health. 2007 . Menopausal hormone replacement therapy use and cancer: Questions and answers. Fact Sheet Retrieved October 5, 2007, from http://www.cancer.gov/cancertopics/factsheet/Risk/menopausal-hormones
  • Nedrow , A. , Miller , J. , Walker , M. , Nygren , P. , Huffman , L. H. and Nelson , H. D. 2006 . Complementary and alternative therapies for the management of menopause-related symptoms: A systematic evidence review . Arch Int Med , 166 : 1453 – 65 .
  • New Zealand Guidelines Group. 2004/2007 . Hormone replacement therapy. Evidence based best practice guideline summary update Retrieved December 4, 2007, from http://www.nzgg.org.nz/guidelines/0078/HRT_summary_web.pdf
  • Office of Women's Health. 2004 . Menopause campaign. OWH Update Retrieved October 5, 2007, from http://www.fda.gov/womens/owhupdate/dec2004.html
  • Palmlund , I. 2006 . Loyalties in clinical research on drugs: The case of hormone replacement therapy . Soc Sci & Med , 63 : 540 – 51 .
  • Petitti , D. B. 2002 . Hormone replacement therapy for prevention. More evidence, more pessimism . J Am Med Assoc , 288 : 99 – 101 .
  • Practice Committee of the American Society for Reproductive Medicine. 2008 . Estrogen and progestogen therapy in postmenopausal women . Fertil & Steril , 90 : S88 – S102 .
  • Prentice , R. , Langer , R. , Anderson , G. and Barad , D. 2005 . Prentice et al. respond to “How far can epidemiologists get with statistical adjustment?” . Am J Epidemiol , 162 : 419 – 20 .
  • Rees , M. 2006 . Gynecological oncological perspective on management of the menopause . J Cancer Surg , 32 : 892 – 7 .
  • Rock , J. and Jones , H. , eds. 2008 . Te Linde's Operative Gynecology, , 10th ed. Philadelphia : Lippincott Williams & Wilkins. .
  • Rose , N. 2006 . Disorders without borders? The expanding scope of psychiatric practice . Biosocieties , 1 : 465 – 84 .
  • Sackett , D. 2002 . The arrogance of preventative medicine . Can Med Assoc J , 167 : 363 – 4 .
  • Scott , J. 1988 . Deconstructing equality versus difference: Or, the uses of post structural theory for feminism . Feminist Stud , 14 : 33 – 50 .
  • Shuster , L. T. , Gostout , B. S. , Grossardt , B. R. and Rocca , W. A. 2008 . Prophylactic oopherectomy in premenopausal women and long-term health . Menopause Int , 14 : 111 – 6 .
  • Statistics New Zealand. 2006 . Census of population and dwellings 2006 Statistics, , New Zealand : Government Printer. .
  • Stefanick , M. 2005 . Estrogens and progestins: Background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration . Am J Med , 118 : 64 – 73 .
  • Stephenson , J. 2003 . FDA orders estrogen safety warnings: Agency offers guidance for HRT use . J Am Med Assoc , 289 : 537 – 8 .
  • Tiles , M. 1993 . The normal and pathological: The concept of a scientific medicine . Br J Philos Sci , 44 : 729 – 42 .
  • Turner , B. 1992 . Regulating bodies: Essays in medical sociology. London : Routledge. .
  • Turner , B. 1997 . “ Foreword: From governmentality to risk, some reflections on Foucault's contribution to medical sociology ” . In Foucault, Health and Medicine Edited by: Petersen , A. and Bunton , R. London : Routledge .
  • Utian , W. 1999 . An historical perspective on natural and surgical menopause . Menopause , 6 : 83 – 6 .
  • Weedon , C. 1987 . Feminist practice and poststructural theory Oxford : Basil Blackwell .
  • Writing Group for the Women's Health Initiative Investigators. 2002 . Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomised controlled trial . J Am Med Assoc , 288 : 321 – 33 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.